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Multiple cardiovascular complications in a patient with 
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Arterial  and  cardiac  involvement  of  Behcet's  disease  is  a  rare  but  life  threatening  complication.  The  rupture  of  an 
arterial aneurysm might result in sudden death. We report a 54-year-old man with an established diagnosis of Behcet's 
disease who presented with multiple cardiovascular complications that eventually lead to his death. He presented with 
extensive  venous  occlusions,  and  sequentially  developed  right  ventricular  thrombosis  with  multiple  pulmonary 
thromboembolisms, and a pulmonary artery aneurysm. We report this unusual sequence of cardiovascular complications 
in  a  patient  with  Behcet's  disease. 
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INTRODUCTION
Behcet's  disease  (BD)  is  often  complicated  by  vascular 
complications  with  a  clear  preponderance  for  venous  involve-
ment
1).  Arterial  and  cardiac  complications  including  aneurysms, 
arteritis,  and  thrombosis  are  rare  but  life  threatening  com-
plications
2, 3). We report an unusual case of successive vascular 
complications including extensive venous thrombosis, huge right 
ventricular  (RV)  thrombus,  multiple  pulmonary  thromboem-
bolisms,  and  a  pulmonary  artery  aneurysm  (PAA)  rupture  in  a 
patient  with  an  established  diagnosis  of  BD. 
CASE REPORT
In  March,  2003,  a  54-year-old  man  presented  with  cough, 
dyspnea  and  intermittent  fever  that  began  two  months  earlier. 
Two years previously, he was diagnosed with BD based on the 
clinical  manifestations  of  recurrent  oral  and  genital  ulcers,  skin 
manifestations  including  erythema  nodosum  and  papulopustular 
lesions, and a positive pathology test. He had a previous history 
of  recurrent  venous  occlusions  at  multiple  sites,  including  the 
common  femoral  vein,  great  saphenous  vein  and  inferior  vena 
cava. He had been on maintenance coumadin therapy until eight 
m o n t h s  e a r l i e r  w h e n  h e  s t o p p e d  t r e a t m e n t  a n d  w a s  l o s t  t o  
follow  up.
On  examination,  his  body  temperature,  heart  rate  and  blood 
pressure were 38.1℃, 110/min and 120/80 mmHg, respectively. 
Multiple  discrete  round  ulcers  were  observed  on  his  lower  lip 
mucosa,  tongue  and  scrotum.  The  skin  examination  showed 
multiple 0.2 cm sized papules and pustules on both palms. The 
chest  examinations  showed  no  abnormal  findings.  The 
auscultation  of  the  heart  revealed  a  rapid  beat  without  a 
murmur. 
The initial complete blood count revealed a hemoglobin count 
of  12.6  g/dL,  a  platelet  count  of  368×10
9/L,  and  a  white  cell 
count of 10.6×10
9/L. The ESR was elevated to 73 mm/hr and 
the  C-reactive  protein  was  positive  at  4.7  mg/dL.  The 
anticardiolipin  antibodies  were  negative  but  the  lupus  antico-
agulant  was  positive  (92.7  sec).  The  plasma  homocysteine 
concentration was 19.9 mol/L (normal, 4.5-12.4 mol/L). The HLA 
B 5 1  t e s t  w a s  n e g a t i v e .  T h e  a n t i t h r o m b i n  I I I ,  p r o t e i n  C  a n d  S  
levels  were  within  the  normal  range.  The  chest  X-ray  revealed 
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Figure  1.  Echocardiographic  findings  show  mobile  intracardiac  mass  (1.3×2.0  cm)  in  the  right  ventricle  (A).  Lung  perfusion  scan  shows  multiple 
perfusion  defects  on  both  lung  fields  (B).
Figure  2.  Chest  CT  finding  shows  a  rupture  of  the  right  pulmonary 
artery  aneurysm  with  a  thrombus  within  the  aneurysm.
scan  revealed  a  large  mass  in  the  RV.  Transthoracic 
echocardiography showed a mobile ill-defined 2.0×1.3 cm sized 
mass that was attached to the tip of the papillary muscle of RV 
but  valvular  vegetation  was  not  observed  (Figure  1A).  The 
ventricular  functions  were  normal.  The  lung  scan  revealed 
multiple perfusion defects on the right upper, right lower, and left 
lower  lung  fields  (Figure  1B).  Doppler  ultrasonography  of  the 
lower  extremities  did  not  show  venous  thrombosis.
Coumadin  and  methylprednisolone  24  mg/d  were  started 
under a diagnosis of BD complicated by intracardiac thrombosis 
and  multiple  pulmonary  thromboembolisms,.  His  symptoms 
improved rapidly. After the coumadin treatment for one year, the 
right  ventricular  thrombus  was  completely  resolved. 
In October 2004, he suddenly developed a hemoptysis of 700 
mL  associated  with  chest  pain  and  dyspnea.  The  body 
temperature, heart rate, respiratory rate and blood pressure were 
38℃, 140/min, 44/min and 110/70 mmHg, respectively. Coarse 
crackles  were  heard  over  both  lung  fields.  The  complete  blood 
count showed a hemoglobin level, a white blood cell count and 
a  platelet  count  of  11.0  g/dL,  16.4×10
9/L  and  405×10
9/L, 
respectively.  The  coagulation  profile,  ESR,  CRP,  and  blood 
chemistry were within the normal limits. The chest CT scan and 
pulmonary  angiography  revealed  a  pulmonary  hemorrhage  from 
a  rupture  of  the  right  pulmonary  artery  and  a  thrombus  within 
the  aneurysm  (Figure  2). 
The  patient  was  diagnosed  with  a  rupture  of  PAA  and  was 
started  on  high  dose  glucocorticoid  and  cyclophosphamide 
pulse  therapy.  After  the  completion  of  6  cycles  of  cyclopho-
sphamide therapy, he was maintained on azathioprine 100 mg/d 
and methylprednisolone 8 mg/d. His progress was uneventful for 
10 months, and the PAA decreased in size. In August 2005, he 
developed recurrent hemoptysis, which resolved with high dose 
glucocorticoid therapy. However, he died during a third episode 
of massive hemoptysis in October 2005, twelve months after the 
initial  presentation.
DISCUSSION
Since  the  main  pathological  feature  of  BD  is  vasculitis,  the 
condition is often complicated by vascular complications with an 
incidence of vascular involvement ranging from 7 to 29%
2).  The 
venous  lesions  are  mainly  venous  occlusions,  while  arterial 
lesions are either arterial aneurysms or arterial occlusions. Arterial 
complications,  particularly  when  multiple  vessels  are  involved, 
have  grave  consequences  often  leading  to  mortality.  The 
A BThe  Korean  Journal  of  Internal  Medicine  :  Vol.  23,  No.  2,  June  2008 102
pathogenesis  of  thrombosis  in  BD  is  unclear.  Endothelial  cell 
injury  by  the  deposition  of  immune  complexes  has  been 
implicated  as  an  important  cause  of  hypercoagulability  and 
thrombosis. Vascular inflammation can lead to the enhancement 
of platelet aggregation and an impairment of fibrinolysis resulting 
in a thrombosis
4, 5). Recently, the von Willebrand factor antigen
6), 
hyperhomocysteinemia,  and  antiphospholipid  antibodies  were 
r e p o r t e d  t o  p l a y  a  r o l e  i n  t h r o m b u s  f o r m a t i o n  i n  B D
7, 8). 
Thrombosis  can  occur  in  any  type  of  vein  or  artery.  However, 
thrombosis  within  the  cardiac  chamber  is  extremely  rare
9) a n d  
can  only  occur  in  settings  where  the  immune  system  is 
extensively  activated.  This  is  because  the  endocardium  is  less 
prone  to  damage  from  circulating  immune  complexes  and 
various  inflammatory  mediators  due  to  high  velocity  dynamic 
blood  flow  within  the  cardiac  chambers.  In  our  patient,  the 
increased  lupus  anticoagulant  and  plasma  homocysteine 
concentration  was  documented  during  the  severe  disease  flare 
up  resulting  in  a  thrombosis  of  the  pulmonary  artery  and  RV. 
Our  case  demonstrates  that  multiple  thrombophilic  factors  act 
cumulatively  to  trigger  a  fulminant  thrombotic  phenomenon. 
Aneurysms  occupy  approximately  60%  of  reported  arterial 
lesions  associated  with  BD
10).  The  aorta  is  the  most  commonly 
affected artery followed by the pulmonary artery
11). PAA is known 
to  occur  as  a  result  of  immune-mediated  vasculitis
1).  The 
consequent  neovascularization  and  degeneration  of  arterial  wall 
result in the formation of an aneurysm
12). Hemoptysis is the main 
presenting  symptom  but  thrombi  within  PAA  can  cause 
secondary  ischemia  in  the  lung  parenchyma.  Medical  treatment 
with  immunosuppressive  agents  is  preferred  over  surgery 
because a recurrent aneurysm or fistula at the anastomotic site 
is a common complication after a surgical resection
13). There are 
reports  of  the  regression  of  PAA  associated  with  BD  after  a 
treatment  with  high  dose  glucocorticoid  and  cyclophosphamide 
combination
14, 15).  However,  the  successful  control  of  the 
symptoms with these therapeutic regimens is not always enough 
to prevent a recurrence or rupture. Once an aneurysm develops, 
it carries the risk  of rupture at any time. Approximately 30% of 
BD  patients  with  PAA  die  within  2  years
15).   
When  a  BD  patient  with  thrombophilic  tendency  experiences 
a major flare in the disease activity, a search for other vascular 
complications  is  recommended  because  multiple  catastrophic 
vascular  events  can  be  triggered  by  the  inflammation.
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